An arm of a New York Life Insurance Company wants to help investors invest in improving people’s health.
IndexIQ, part of New York Life Investment Management LLC, is joining with the American Heart Association to introduce the IQ Healthy Hearts ETF (HART), which trades on the New York Stock Exchange.
New York Life Investments sees the fund as an example of an investment arrangement based on an effort to take environmental, social and [corporate] governance (ESG) criteria into account.
The HART ETF will invest in companies that fit with AHA objectives, such as those that provide:
- Diagnosis or treatment of cardiovascular diseases.
- Manufacturing and distribution of healthy food or wellness products.
- Services allowing people to access information about their health and thereby make better decisions about their lifestyles.
- Solutions for people to track their fitness and engage in a healthy lifestyle.
A fund fact sheet shows that, as of Jan. 14, the top holdings were Eli Lilly and Company, Apple Inc., Johnson & Johnson, NIKE Inc. Class B, Novo Nordisk A/S Class B, Novartis AG, Abbott Laboratories, Medtronic PLC, Merck & Co. Inc. and Bristol-Myers-Squibb Co.
The new HART fund will make regular contributions to the AHA’s Social Impact Find, according to New York Life Investments.
“The Social Impact Fund supports entrepreneurs, small businesses and organizations in under-served communities whose programs address economic and social conditions that can affect a person’s health,” the AHA says on its website. “These issues include social cohesion, employment, education, housing and food access.”
The AHA Social Impact Fund was formed in 2019 and has given $35 million to 39 organizations, it says.